Wang Lian-Xin, Miao Qing, Xie Yan-Ming, Chen Da-Can, Sun Su-Lun, Zhang Hong-Chun, Jia Zhong-Wu, Li Tie-Nan, Zhu Jia, Shi Li-Qing, Song Ping, Gao Feng, Wei Bao-Lin, Feng Cui-Ling, Qu Yi-Qing, Qu Ni-Ni, Yu Xue-Feng, Zhang Nian-Zhi, Yu Xue-Qing
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
Xiyuan Hospital,China Academy of Chinese Medical Sciences Beijing 100091,China.
Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(24):5277-5281. doi: 10.19540/j.cnki.cjcmm.20191105.501.
Pudilan Xiaoyan Oral Liquid has effects in clearing away heat and detoxifying,and is used to treat pharynx and throat swelling caused by the syndrome of excessive heat and toxin accumulation. Its efficacy is to relieve swelling and pain( redness,swelling and hot pain). It is included in the Chinese Pharmacopoeia of 2015 Edition,and has been listed in provincial health insurance directories of Shaanxi,Jiangsu,Liaoning,Hunan,Tianjin,Xinjiang and Hebei. It has been recommended by health departments of Beijing,Chongqing and other provinces as a preferred drug for the prevention and treatment of H1 N1 and HFMD,and listed in the diagnosis and Treatment Guide of HFMD by the Ministry of Health,the Clinical Application Guide of Chinese Patent Medicine edited by the Lung Department Disease Branch of China Association of Chinese Medicine,and the Clinical Practice Guide of Single Administration/Combined Administration of Antibiotics in Treatment of Common Infectious Diseases by China Association of Chinese Medicine. To further improve the clinician's understanding of drugs and better guide the rational clinical application,we invited front-line clinical experts from respiratory department,infectious department and dermatology of traditional Chinese and Western medicine to develop and compile the expert consensus. The consensus fully considered the clinical evidence and the expert clinical experience to give recommendations for clinical problems with evidence support and consensus suggestions for clinical problems without evidence support by the nominal group method.This consensus is based on clinical research evidence and expert experience in a simple and clear format,which provides a preliminary reference for the clinical use of the drug.
蒲地蓝消炎口服液具有清热解毒作用,用于治疗热毒蕴结证所致的咽喉肿痛。其功效为消肿止痛(红肿热痛)。它被收载于《中国药典》2015年版,已被列入陕西、江苏、辽宁、湖南、天津、新疆和河北等省的医保目录。它被北京、重庆等省市卫生部门推荐为预防和治疗甲型H1N1流感及手足口病的首选药物,并被列入卫生部《手足口病诊疗指南》、中华中医药学会肺病分会主编的《中成药临床应用指南》以及中华中医药学会《常见传染病中西医结合诊疗指南·抗菌药物单独/联合使用临床实践指南》。为进一步提高临床医生对该药的认识,更好地指导临床合理应用,我们邀请了中西医结合呼吸科、感染科及皮肤科一线临床专家制定并编写了本专家共识。本共识充分考虑临床证据及专家临床经验,采用名义群体法对有证据支持的临床问题给出推荐意见,对无证据支持的临床问题给出专家共识建议。本共识基于临床研究证据及专家经验,以简洁明了的形式呈现,为该药的临床应用提供了初步参考。